The invention relates to the identification of a novel gene, TMS1, which is transcriptionally
silenced as a result of methylation. Nucleic acids and polypeptides are provided
as are methods and tools for diagnosing and treating disorders characterized by
such methylation, and/or abnormally low levels of TMS1 expression products.
